Provided by Tiger Trade Technology Pte. Ltd.

ResMed

218.27
-1.3100-0.60%
Volume:912.33K
Turnover:198.92M
Market Cap:31.49B
PE:20.93
High:221.29
Open:220.44
Low:215.97
Close:219.58
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.71
T/O Rate:0.64%
Dividend:2.40
Dividend Rate:1.10%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.78
PE(LYR):20.93

Loading ...

Resmed Q4 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 07

Resmed Q4 Adjusted EPS USD 2.95 Vs. IBES Estimate USD 2.89

Reuters
·
Aug 07

ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate

Benzinga Earnings
·
Aug 07

Resmed - Guides to Return over $1.85 Bln to Shareholders in Fy2027; Raises Qtrly Dividend 10% to $0.66

THOMSON REUTERS
·
Aug 07

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

THOMSON REUTERS
·
Aug 07

ResMed Director Peter C. Farrell Disposes of 8,000 Common Shares Worth $1.8 Million

Reuters
·
Aug 07

ResMed Updates July CDI Balances Amid Dual-Listing Share Movements

TIPRANKS
·
Aug 05

Statement of CDIs on Issue - RMD-RMD.N

Reuters
·
Aug 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Resmed (RMD) and High Tide (HITI)

TIPRANKS
·
Aug 05

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 04

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 01

Sell Winning Stocks at 0% Federal Tax, Reinvest Same Day: Wash Sale Rules Don't Apply

Deep News
·
Jul 31

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 30

NYSE Order Imbalance 75737.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

BofA Adjusts Price Target on ResMed to $320 From $310

MT Newswires Live
·
Jul 24

ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says

MT Newswires Live
·
Jul 22

Resmed Bulls Think Acquisition Timing Looks Awkward

Dow Jones
·
Jul 21

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

MT Newswires Live
·
Jul 17

ResMed downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jul 16